Riskpilot← Back to searchSign inGet full accessINTERFARM AS
ASActiveOrg 933606546Dølasletta 5, 3408 TranbyWholesale of pharmaceutical and medical goods · NACE 4646Est. 19832 employees
Revenue 2024
NOK 5,9M
+3% vs 2023
EBITDA margin
-0.1%
-115% vs 2023
Equity ratio
79.1%
Financial strength
Net profit 2024
NOK -6K
+85% vs 2023
| Revenue | NOK 5,9M | +3% |
| EBITDA | NOK -9K | -115% |
| Net profit | NOK -6K | +85% |
| Total assets | NOK 3,4M | -10% |
| Equity | NOK 2,7M | +0% |
| Employees | 2 | — |
Legal name
INTERFARM AS
Org number
933606546
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. januar 1983
Share capital
—
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Address
Dølasletta 5, 3408 Tranby
Phone
+4767581130
Email
post@interfarm.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 474 | 7 302 | 7 206 | 8 693 | 6 193 | 5 989 | 5 568 | 5 926 | 5 679 | 5 519 | 6 471 | 5 979 | 5 787 | 5 942 |
| Staff expenses | −983 | −2 130 | −2 054 | −2 127 | −1 680 | −1 493 | −1 471 | −1 477 | −1 500 | −1 005 | −1 464 | −1 528 | −1 582 | −1 645 |
| EBITDA | 38 | 1 185 | 1 059 | 953 | 622 | 199 | −246 | 73 | −376 | 458 | 331 | 419 | 58 | −9 |
| Depreciation & amort. | −11 | −67 | −68 | −9 | −9 | −9 | −9 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 27 | 1 117 | 991 | 944 | 613 | 190 | −255 | 73 | −376 | 458 | 331 | 419 | 58 | −9 |
| Net financials | 168 | 73 | 7 | −23 | −140 | 26 | −52 | −15 | −32 | −72 | −37 | −225 | −107 | 8 |
| Profit before tax | 195 | 1 190 | 999 | 922 | 473 | 216 | −307 | 57 | −408 | 385 | 294 | 194 | −49 | −1 |
| Tax | 55 | 336 | 284 | 251 | 133 | 57 | −67 | 18 | −87 | 92 | 69 | 45 | −6 | 6 |
| Net profit | 140 | 855 | 715 | 671 | 339 | 159 | −240 | 40 | −320 | 293 | 225 | 149 | −43 | −6 |
| Item | 2008 | 2009 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 175 | 4 027 | 4 039 | 5 249 | 3 910 | 3 475 | 3 406 | 3 357 | 2 934 | 3 244 | 3 704 | 3 680 | 3 737 | 3 360 |
| Equity | 2 093 | 1 948 | 2 198 | 3 066 | 2 800 | 2 560 | 2 320 | 2 360 | 2 039 | 2 333 | 2 557 | 2 706 | 2 663 | 2 657 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 082 | 2 079 | 1 841 | 2 183 | 1 110 | 916 | 1 086 | 998 | 894 | 911 | 1 147 | 974 | 1 074 | 703 |
| Total debt | 1 082 | 2 079 | 1 841 | 2 183 | 1 110 | 916 | 1 086 | 998 | 894 | 911 | 1 147 | 974 | 1 074 | 703 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20082024
Equity ratio
79.1%
This company
38.2%
Market median
+107% vs market
20082024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20082024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20082024
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
20082024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Chairman | 2005 | — | — | |
| Board of Directors | 2005 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INTERFARM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Advocat Unn Skomsøy | Chairman | 0 companies |
| Odd Gunnar Skomsøy | Chairman | 0 companies |
| Arne Bertol Svilaas | Board of Directors | 0 companies |